HomeAbout usHospitalsSearchLogin
Your medical data, safe and secure.
Name
Pazopanib
Description
Pazopanib is a small molecule inhibitor of multiple protein tyrosine kinases with potential antineoplastic activity. It is developed by GlaxoSmithKline and was FDA approved on October 19, 2009.
No brand information found.
